TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -25.84%-1.62M | ---- | 84.73%-1.29M | ---- | 89.21%-8.41M | ---- | -285.80%-77.96M | ---- | 12.78%-20.21M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 48.54%-778K | ---- | 29.97%-1.51M | ---- | 23.25%-2.16M | ---- | -111.19%-2.81M | ---- | -22.31%-1.33M |
Interest expense - adjustment | ---- | -39.67%15.49M | ---- | -35.10%25.68M | ---- | -19.46%39.57M | ---- | -0.51%49.13M | ---- | 10.21%49.38M |
Investment loss (gain) | ---- | -77.17%-9.2M | ---- | -4,019.05%-5.19M | ---- | 41.40%-126K | ---- | ---215K | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | 888.16%5.43M | ---- | --549K | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | -57.13%2.61M | ---- | --6.08M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -57.13%2.61M | ---- | --6.08M | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | -95.16%467K | ---- | 1,385.89%9.66M | ---- | -42.78%-751K | ---- | 83.08%-526K | ---- | ---3.11M |
-Fair value of investment properties (increase) | ---- | -74.70%277K | ---- | 601.92%1.1M | ---- | 169.33%156K | ---- | 92.76%-225K | ---- | ---3.11M |
-Other fair value changes | ---- | -97.78%190K | ---- | 1,043.99%8.56M | ---- | -201.33%-907K | ---- | ---301K | ---- | ---- |
Asset sale loss (gain): | ---- | --312K | ---- | ---- | ---- | 125.39%2.31M | ---- | 2,660.00%1.02M | ---- | -229.03%-40K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | --2.28M | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---27K | ---- | ---- | ---- | 2,300.00%24K | ---- | 102.50%1K | ---- | -229.03%-40K |
-Loss (gain) from selling other assets | ---- | --339K | ---- | ---- | ---- | ---- | ---- | --1.02M | ---- | ---- |
Depreciation and amortization: | ---- | -15.00%1.68M | ---- | -13.81%1.97M | ---- | -36.13%2.29M | ---- | -4.22%3.58M | ---- | 502.58%3.74M |
Exchange Loss (gain) | ---- | -43.54%-600K | ---- | -231.45%-418K | ---- | -93.11%318K | ---- | 1,396.07%4.61M | ---- | 89.63%-356K |
Special items | ---- | 99.29%-190K | ---- | -17.13%-26.94M | ---- | -172.95%-23M | ---- | 1,147.61%31.53M | ---- | -107.33%-3.01M |
Operating profit before the change of operating capital | ---- | -39.29%8.17M | ---- | 27.32%13.47M | ---- | 26.46%10.58M | ---- | -66.64%8.36M | ---- | -57.39%25.07M |
Change of operating capital | ||||||||||
Accounts payable increase (decrease) | ---- | -89.59%78K | ---- | 150.50%749K | ---- | 105.96%299K | ---- | -329.51%-5.02M | ---- | 310.80%2.19M |
prepayments (increase)decrease | ---- | -91.13%144K | ---- | 1,312.17%1.62M | ---- | 104.97%115K | ---- | -431.23%-2.31M | ---- | 8.22%698K |
Special items for working capital changes | ---- | -32.18%51.55M | ---- | 142.40%76.02M | ---- | 313.98%31.36M | ---- | -81.13%7.58M | ---- | -62.13%40.14M |
Cash from business operations | 75.54%21.99M | -34.73%59.95M | -13.03%12.52M | 116.90%91.85M | 956.12%14.4M | 391.92%42.35M | -105.96%-1.68M | -87.36%8.61M | 217.27%28.23M | -58.59%68.09M |
Other taxs | -34.89%-4.03M | -69.30%-7.89M | 14.13%-2.99M | 37.85%-4.66M | 1.16%-3.48M | 24.38%-7.5M | 39.42%-3.52M | 19.30%-9.92M | 30.78%-5.81M | 2.13%-12.29M |
Interest received - operating | 86.63%754K | -48.54%778K | -31.76%404K | -29.97%1.51M | -55.29%592K | -23.25%2.16M | 34.42%1.32M | 111.19%2.81M | 31.51%985K | 22.31%1.33M |
Net cash from operations | 88.22%18.71M | -40.44%52.84M | -13.66%9.94M | 139.68%88.7M | 396.68%11.51M | 2,359.07%37.01M | -116.58%-3.88M | -97.37%1.51M | 173.47%23.4M | -62.65%57.14M |
Cash flow from investment activities | ||||||||||
Sale of fixed assets | ---- | --273K | --91K | ---- | ---- | ---- | ---- | -90.00%9K | -90.22%9K | 542.86%90K |
Purchase of fixed assets | ---- | -72.73%-152K | 59.15%-29K | 35.77%-88K | 4.05%-71K | 92.34%-137K | 93.08%-74K | -3,275.47%-1.79M | -2,572.50%-1.07M | 84.41%-53K |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --9.78M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | -82.63%2.7M | -85.11%2.31M | 5.89%15.53M | 2,059.81%15.53M | 1,434.00%14.67M | --719K | --956K | ---- | ---- |
Cash on investment | ---- | ---- | ---- | 77.81%-3.51M | 42.92%-3.51M | -40.79%-15.83M | ---6.15M | -12,821.84%-11.24M | ---- | ---87K |
Net cash from investment operations | ---- | -76.37%2.82M | -80.12%2.38M | 40.64%11.93M | 317.08%11.95M | 170.30%8.48M | -419.25%-5.5M | -24,032.00%-12.07M | -2,138.46%-1.06M | 84.66%-50K |
Net cash before financing | 51.92%18.71M | -44.70%55.66M | -47.51%12.31M | 121.22%100.63M | 349.99%23.46M | 530.75%45.49M | -142.01%-9.38M | -118.50%-10.56M | 170.26%22.34M | -62.60%57.09M |
Cash flow from financing activities | ||||||||||
New borrowing | --170K | -157.18%-1.24M | ---- | --2.16M | --2.16M | ---- | ---- | ---- | 10,100.00%2.5M | ---- |
Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,796.00%-474K | ---- | 98.89%-25K |
Issuing shares | 84.17%7.82M | --4.25M | --4.25M | ---- | ---- | 919.85%101.99M | 650.15%72.08M | --10M | --9.61M | ---- |
Interest paid - financing | ---183K | ---- | ---- | ---- | ---- | 63.08%-443K | 63.08%-443K | 25.00%-1.2M | 25.00%-1.2M | ---1.6M |
Dividends paid - financing | ---- | 33.35%-1.22M | 34.28%-1.24M | -54.75%-1.83M | ---1.89M | 53.53%-1.18M | ---- | -8.88%-2.54M | ---2.49M | 49.17%-2.33M |
Issuance expenses and redemption of securities expenses | 23.05%-29.12M | 21.94%-65.67M | -372.98%-37.84M | 55.84%-84.12M | 91.66%-8M | -89.16%-190.51M | -119.05%-95.9M | ---100.72M | ---43.78M | ---- |
Net cash from financing operations | 38.92%-21.69M | 23.77%-65.16M | -317.15%-35.51M | 7.09%-85.48M | 66.18%-8.51M | 4.89%-92.01M | 30.11%-25.17M | -1,077.90%-96.74M | -1,054.91%-36.01M | -20.11%-8.21M |
Effect of rate | 43.63%-1.95M | 58.17%-2.47M | -189.13%-3.46M | -282.78%-5.9M | 133.35%3.88M | -61.66%3.23M | 137.94%1.66M | 300.36%8.42M | -1,141.81%-4.39M | 49.37%-4.2M |
Net Cash | 87.14%-2.98M | -162.74%-9.51M | -255.17%-23.19M | 132.58%15.15M | 143.26%14.95M | 56.65%-46.52M | -152.70%-34.55M | -319.56%-107.3M | 60.83%-13.67M | -66.48%48.87M |
Begining period cash | -11.39%93.18M | 9.65%105.16M | 9.65%105.16M | -31.10%95.91M | -31.10%95.91M | -41.53%139.19M | -41.53%139.19M | 23.10%238.08M | 23.10%238.08M | 246.03%193.41M |
Cash at the end | 12.42%88.25M | -11.39%93.18M | -31.58%78.5M | 9.65%105.16M | 7.93%114.74M | -31.10%95.91M | -51.68%106.31M | -41.53%139.19M | 38.45%220.02M | 23.10%238.08M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.